(JMBA) JPMorgan s (Ireland) ICAV - Ratings and Ratios
Emerging, Markets, Bonds, Sovereign, Debt, Securities
Description: JMBA JPMorgan s (Ireland) ICAV
The JPMorgan ETFs (Ireland) ICAV - USD Emerging Markets Sovereign Bond UCITS ETF USD (acc) is an exchange-traded fund that tracks the Morningstar EM Sov Bd GR USD index, providing exposure to emerging markets sovereign bonds denominated in USD. The fund is listed on XETRA under the ticker symbol JMBA.
As a Global Emerging Markets Bond ETF, it offers investors a diversified portfolio of sovereign debt from emerging economies. With a substantial Assets Under Management (AUM) of approximately $7.83 billion USD ( converted from 6937.00M EUR), the fund demonstrates a considerable presence in the market.
To evaluate the funds performance, we can consider key metrics such as tracking error, liquidity, and expense ratio. Although not provided, these metrics are crucial in assessing the funds ability to replicate the underlying index, its marketability, and cost-effectiveness. A lower tracking error and expense ratio generally indicate better performance, while higher liquidity is desirable for ease of buying and selling.
From a technical analysis perspective, the funds price movement can be assessed using various indicators. Although the provided Simple Moving Averages (SMA20, SMA50, SMA200) suggest a relatively stable short-term trend, the funds price is currently below its longer-term averages, indicating potential underlying weakness. The Average True Range (ATR) of 0.42, representing 0.45% of the current price, implies moderate volatility.
To make informed investment decisions, it is essential to consider additional KPIs, such as the funds yield, duration, and credit quality. These metrics can help investors understand the funds income generation, interest rate sensitivity, and potential credit risk. By analyzing these factors, investors can better evaluate the funds suitability for their investment objectives and risk tolerance.
Additional Sources for JMBA ETF
JMBA ETF Overview
Market Cap in USD | 8,185m |
Category | Global Emerging Markets Bond |
IPO / Inception | 2019-12-03 |
JMBA ETF Ratings
Growth Rating | 4.65 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 0.44 |
Analysts | - |
Fair Price Momentum | 85.77 EUR |
Fair Price DCF | - |
JMBA Dividends
Currently no dividends paidJMBA Growth Ratios
Growth Correlation 3m | 19.5% |
Growth Correlation 12m | -20.1% |
Growth Correlation 5y | 26.5% |
CAGR 5y | 0.23% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | 0.24 |
Alpha | -6.95 |
Beta | 0.132 |
Volatility | 7.08% |
Current Volume | 0k |
Average Volume 20d | 0k |
As of July 06, 2025, the stock is trading at EUR 92.99 with a total of 1 shares traded.
Over the past week, the price has changed by +0.13%, over one month by -1.16%, over three months by -2.64% and over the past year by -1.60%.
Neither. Based on ValueRay´s Analyses, JPMorgan s (Ireland) ICAV is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 4.65 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JMBA is around 85.77 EUR . This means that JMBA is currently overvalued and has a potential downside of -7.76%.
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
According to our own proprietary Forecast Model, JMBA JPMorgan s (Ireland) ICAV will be worth about 93 in July 2026. The stock is currently trading at 92.99. This means that the stock has a potential downside of -0.01%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 93 | -0% |